Jon‐Paul Khoo
0009-0006-1860-527X
Publication & Citation Trends
Publications
21 total
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies OA
Cited by 21
Semantic Scholar
P.095 Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder
Cited by 0
Semantic Scholar
A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don’t work well enough?
Cited by 68
Semantic Scholar
P.096 Efficacy of agomelatine on anxiety symptoms and functional impairment in adult patients with generalized anxiety disorder
Cited by 0
Semantic Scholar
The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia OA
Cited by 23
Semantic Scholar
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 OA
Cited by 7,265
Semantic Scholar
12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25-50 mg/day) versus escitalopram (10-20 mg/day) in out-patients with severe generalized anxiety disorder.
Cited by 28
Semantic Scholar
Research Topics
Bipolar Disorder and Treatment
(6)
Treatment of Major Depression
(5)
Tryptophan and brain disorders
(5)
Health disparities and outcomes
(4)
Natural Compound Pharmacology Studies
(3)
Affiliations
Barwon Health
Deakin University
Kaohsiung Medical University
The University of Queensland
Park Centre for Mental Health